Sort publications on year
-
Pharmaco-Economics
Intérêt des bases de remboursement de l’Assurance maladie pour l’analyse de la prise en charge des maladies chroniques : le cas de l’épilepsie
FAGNANI F, VESPIGNANI H, KUSNIK-JOINVILLE O, BERTRAND M, MURAT C, LEVY-BACHELOT L, KAHANE P
Presse Med ; 2013;42:285-292
-
Pharmaco-Economics
Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses
YE X, LAFUMA A, TORRETON E, ARNAUD A
BMC Health Serv Res ; 2013;13(1):186
-
Pharmaco - Epidemiology
Hereditary angioedema with C1 inhibitor deficiency : clinical presentation and quality of life of 193 French patients
BOUILLET L, DAVID LAUNAY D, FAIN O, BOCCON-GIBOD I, LAURENT J, MARTIN L, MONTAUBAN V, FINCK K, BOUÉE S, GOMPEL A, KANNY G
Ann Allergy Asthma Immunol ; 2013;111:290-294
-
Pharmaco - Epidemiology
Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross Sectional Study
GRANDFILS N, DETOURNAY B, ATTALI C, JOLY D, SIMON D, VERGES B, TOUSSI M, BRIAND Y, DELAITRE O
Int J Endocrinol ; 2013;2013:640632
-
Pharmaco - Epidemiology
Facteurs associés à l’hospitalisation des personnes diabétiques adultes en France Entred 2007
ASSOGBA F , PENFORNIS F , DETOURNAY B, LECOMTE P, BOURDEL-MARCHASSON I, DRUET C , WEILL A , FAGOT-CAMPAGNA A, FOSSE-EDORH S
BEH ; 2013;37-38:454-463
-
Pharmaco - Epidemiology
Comparison of clinical efficacy: Nd:YAG laser rates after implantation of AcrySof(®) SN60WF, Akreos(®) AO-MI60 and Hoya(®) YA-60BB
BOURDIOL DUCASSE AM, GUERZIDER V, VELASQUE L, DOMINGUEZ M, LAFUMA A, ROBERT J
J Fr Ophtalmol ; 2013;36:575-582
-
Pharmaco-Economics
Aspects économiques du diabète en France : quelles évolutions?
DETOURNAY B
Med Mal Metab ; 2013;7(3):224-227
-
Pharmaco - Epidemiology
Use of vildagliptin in management of type 2 diabetes : effectiveness, treatment persistence and safety from the 2-year real-life VILDA study
SIMON D, DETOURNAY B, ESCHWEGE E, BOUEE S, BRINGER J, ATTALI C, DEJAGER S
Diabetes Ther ; 2014;5(1):207-224
-
Pharmaco - Epidemiology
Types 2 diabetes prevalence, health status and quality of care among the North African immigrant population living in France
FOSSE-EDORH S, FAGOT-CAMPANA A, DETOURNAY B, BIHAN H, GAUTIER A, DALICHAMPT M, DRUET C
Diabetes Metab ; 2014;40(2):143-50
-
Pharmaco - Epidemiology
Management of focal epilepsy in adults treated with polytherapy in France : The direct cost of drug resistance (ESPERA study)
DE ZÉLICOURT M, DE TOFFOL B, VESPIGNANI H, LAURENDEAU C, LÉVY-BACHELOT L, MURAT C, FAGNANI F
Seizure ; 2014;23(5):349-356
-
Pharmaco-Economics
L’évaluation économique dans le champ de la santé
DETOURNAY B
Médecine/Sciences ; 2014;30(5):584-587
-
Pharmaco - Epidemiology
Adjustment disorder with anxiety in old age: Comparing prevalence and clinical management in primary care and mental health care
ARBUS C, HERGUETA T, DUBURCQ A, SALEH A, LE GUERN M-E, ROBERT P, CAMUS V
Eur Psychiatry ; 2014;29:233-238
-
Pharmaco - Epidemiology
[Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: Description according to the 2009 ILAE definition of AED resistance (ESPERA study)]
VESPIGNANI H, DE ZÉLICOURT M, LAURENDEAU C, FAGNANI F, LEVY-BACHELOT L, MURAT C, KAHANE P, DE TOFFOL B
Rev Neurol ; 2014;170(2): 100-109
